Cryoport Selected by Lynden International as the Preferred Cryogenic Logistics Provider

June 10, 2015

Lake Forest, CA, June 10, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced that it has been selected by Lynden International (“Lynden”) as its preferred provider to support cold chain clinical trial logistics for underrepresented diseases in Africa.

Read More

Tags: Clinical Trials Logistics, cryogenic frozen, Global Cold Chain Logistics, Lynden